| Zugriffe | |
|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 317 |
| November 2024 | Dezember 2024 | Januar 2025 | Februar 2025 | März 2025 | April 2025 | Mai 2025 | |
|---|---|---|---|---|---|---|---|
| Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis | 5 | 1 | 9 | 11 | 3 | 6 | 0 |
| Zugriffe | |
|---|---|
| 1065.full.pdf | 173 |
